Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
(Mirabegron + tamsulosin hydrochloride) by DongKoo Bio & Pharma for Overactive Bladder: Likelihood of Approval
(Mirabegron + tamsulosin hydrochloride) is under clinical development by DongKoo Bio & Pharma and currently in Phase I for Overactive...
Data Insights
(Mirabegron + tamsulosin hydrochloride) by DongKoo Bio & Pharma for Benign Prostatic Hyperplasia: Likelihood of Approval
(Mirabegron + tamsulosin hydrochloride) is under clinical development by DongKoo Bio & Pharma and currently in Phase III for Benign...